Arizona is a prime destination for retirees, a big downside to that is an expected increase in those suffering from Alzheimer’s. MORE ⬇️
PHOENIX — Arizona is a prime destination for retirees because of our weather and lower cost of living.
A new report from the Alzheimer’s Association says in 2020 about 150,000 Arizonans suffered from Alzheimer’s. They estimate the number will grow to 200,000 by 2025, a 33% increase in prevalence.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Scientists Reveal New Insights Into the Development of Alzheimer’s DiseaseThe researchers are studying the impact of oxidative stress on the aggregation of peptides. Despite significant progress in research, a cure for many age-related diseases, including Alzheimer's, is yet to be found. The accumulation of peptides in the brain, 'clumping,' is one theory for the develop
Lire la suite »
Number of seniors with Alzheimer’s expected to double by 2050The number of Alzheimer’s patients is expected to double by the year 2050, resulting in 13 million people with the affliction, according to a report.
Lire la suite »
VA will offer coverage of Alzheimer's drug after Medicare passes.VeteransHealth said it will widely cover the expenses for a new Alzheimer's drug after Medicare announced it would not. Leqembi, a $26,500-per-year drug, was approved last month after going through US_FDA's accelerated pathway.
Lire la suite »
VHA to Cover Cost of Drug for Early Alzheimer’sThe Veterans Health Administration will cover the costs of drug treatment Leqembi, the manufacturer Eisai has announced. Veterans in the early stages of the memory-depleting disease Alzheimer’s who meet VHA criteria will be eligible, Eisai said in a statement. The company is developing the drug with Biogen.
Lire la suite »
Number of seniors with Alzheimer’s expected to double by 2050The number of Alzheimer’s patients is expected to double by the year 2050, resulting in 13 million people with the affliction, according to a report.
Lire la suite »